Evidence map›Paper›PMID 33208104›Full record

ArticleBMC genomics2020

A hybrid correcting method considering heterozygous variations by a comprehensive probabilistic model.

Jiaqi Liu, Jiayin Wang, Xiao Xiao, Xin Lai, Daocheng Dai, Xuanping Zhang, Xiaoyan Zhu, Zhongmeng Zhao, Juan Wang, Zhimin Li

Abstract read
In one paragraph

Article in BMC genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiaqi LiuSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Jiayin WangSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China. wangjiayin@mail.xjtu.edu.cn.
Xiao XiaoSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Xin LaiSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Daocheng DaiSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Xuanping ZhangSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Xiaoyan ZhuSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Zhongmeng ZhaoSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Juan WangSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China.
Zhimin LiSchool of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, 710048, China. zhiminli@annoroad.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of the third generation sequencing technology, featuring longer read lengths, has demonstrated great advancement compared to the next generation sequencing technology and greatly promoted the biological research. However, the third generation sequencing data has a high level of the sequencing error rates, which inevitably affects the downstream analysis. Although the issue of sequencing error has been improving these years, large amounts of data were produced at high sequencing errors, and huge waste will be caused if they are discarded. Thus, the error correction for the third generation sequencing data is especially important. The existing error correction methods have poor performances at heterozygous sites, which are ubiquitous in diploid and polyploidy organisms. Therefore, it is a lack of error correction algorithms for the heterozygous loci, especially at low coverages.

resultsIn this article, we propose a error correction method, named QIHC. QIHC is a hybrid correction method, which needs both the next generation and third generation sequencing data. QIHC greatly enhances the sensitivity of identifying the heterozygous sites from sequencing errors, which leads to a high accuracy on error correction. To achieve this, QIHC established a set of probabilistic models based on Bayesian classifier, to estimate the heterozygosity of a site and makes a judgment by calculating the posterior probabilities. The proposed method is consisted of three modules, which respectively generates a pseudo reference sequence, obtains the read alignments, estimates the heterozygosity the sites and corrects the read harboring them. The last module is the core module of QIHC, which is designed to fit for the calculations of multiple cases at a heterozygous site. The other two modules enable the reads mapping to the pseudo reference sequence which somehow overcomes the inefficiency of multiple mappings that adopt by the existing error correction methods.

conclusionsTo verify the performance of our method, we selected Canu and Jabba to compare with QIHC in several aspects. As a hybrid correction method, we first conducted a groups of experiments under different coverages of the next-generation sequencing data. QIHC is far ahead of Jabba on accuracy. Meanwhile, we varied the coverages of the third generation sequencing data and compared performances again among Canu, Jabba and QIHC. QIHC outperforms the other two methods on accuracy of both correcting the sequencing errors and identifying the heterozygous sites, especially at low coverage. We carried out a comparison analysis between Canu and QIHC on the different error rates of the third generation sequencing data. QIHC still performs better. Therefore, QIHC is superior to the existing error correction methods when heterozygous sites exist.

Indexed as

High-Throughput Nucleotide SequencingModels, StatisticalAlgorithmsBayes TheoremSequence Analysis, DNAError correction methodHeterozygous variantHybrid correction methodPacBio sequencingProbabilistic modelSequencing analysisSequencing error

Identifiers

PMID33208104
PMCPMC7677778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.